Cancer Genomics Facility (CGF) The Cancer Genomics Facility (formerly a component of the Cancer Biomarkers Facility) performs quantitative sample assessment, comprehensive genotyping, and transcriptome profiling of tumor tissues, cells and related biological fluids (blood, urine, saliva) of clinical relevance. Analysis incorporates optimized hybridization or primer driven assays for genomic capture and interrogation utilizing state of the art PCR, microarray (bead, plate, cartridge) and, since 2012, sequencing (whole genome, exome, custom targeted) technologies.
The Specific Aims of the CGF are to 1) provide ?state of the art? genomic and transcriptomic services, 2) assist with study design and provide consultation services, 3) provide integrated bioinformatics and statistical analysis support, 4) strategically develop and implement advanced technologies, and 5) provide genomics leadership, administrative, and operational excellence. The facility is located adjacent to the UPCI Tissue and Research Pathology Services shared resource to expedite processing of specimens from diverse preparations ranging from whole mounted tissues (fresh, flash frozen, formalin fixed) to individual tumor stem cells. Protocols routinely incorporate manual and laser capture microdissection to mitigate effects of tumor heterogeneity. Novel methods have been developed to capture and amplify limiting amounts of DNA and RNA (<1ng) from archival (>10 years old) formalin fixed, paraffin embedded specimens. The CGF has generated an extensive reference database of single nucleotide polymorphisms and genomic sequence (70 samples) from ?normal? tissues for patient samples lacking matched germline specimens e.g. to serve as a gene copy number control. CGF collaborates closely with TARPS and CBS to ensure that UPCI investigators have benefit from optimized workflows. The facility routinely provides services to researchers from UPCI Programs, spanning basic, population science, and translational drug discovery and disease-site programs as well as each of the 3.5 SPOREs housed at UPCI. The CGF is also an integral component of the UPCI high- risk, high-reward initiative supporting development of early stage investigators and promoting new research pathways for established investigators. During the current project period investigators in nine UPCI Research Programs used the CGF.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
United States
Zip Code
Li, Changfeng; Zhang, Ying; Cheng, Xing et al. (2018) PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism. Dev Cell 46:441-455.e8
Welty, Starr; Teng, Yaqun; Liang, Zhuobin et al. (2018) RAD52 is required for RNA-templated recombination repair in post-mitotic neurons. J Biol Chem 293:1353-1362
Li, Xiang; George, Subin M; Vernetti, Lawrence et al. (2018) A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX. Lab Chip 18:2614-2631
Singh, Renu; Mehrotra, Shailly; Gopalakrishnan, Mathangi et al. (2018) Population pharmacokinetics and exposure-response assessment of veliparib co-administered with temozolomide in patients with myeloid leukemias. Cancer Chemother Pharmacol :
Nehmeh, Sadek A; Schwartz, Jazmin; Grkovski, Milan et al. (2018) Inter-operator variability in compartmental kinetic analysis of 18F-fluoromisonidazole dynamic PET. Clin Imaging 49:121-127
Woodcock, Chen-Shan Chen; Huang, Yi; Woodcock, Steven R et al. (2018) Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth. J Biol Chem 293:1120-1137
Posluszny, Donna M; Bovbjerg, Dana H; Syrjala, Karen L et al. (2018) Correlates of anxiety and depression symptoms among patients and their family caregivers prior to allogeneic hematopoietic cell transplant for hematological malignancies. Support Care Cancer :
Pulopulos, Matias M; Kozusznik, Malgorzata W (2018) The moderating role of meaning in life in the relationship between perceived stress and diurnal cortisol. Stress 21:203-210
Wang, Zehua; Yang, Bo; Zhang, Min et al. (2018) lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer. Cancer Cell 33:706-720.e9
Volonte, Daniela; Vyas, Avani R; Chen, Chen et al. (2018) Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence. J Biol Chem 293:1794-1809

Showing the most recent 10 out of 1187 publications